The global market for clot management devices is experiencing growth to the rising demand for less invasive procedures and the enormous untapped market for clot management devices in emerging nations. The demand for inexpensive and effective clot control devices is being fuelled by cutting-edge research and development centres and new product introductions by the key companies.
Frequently Asked Questions
The market is segmented based on Segmentation, By Product Type (Neurovascular Embolectomy Devices, Embolectomy Balloon Catheters, Catheter-Directed Thrombolysis (CDT) Devices, and Inferior Vena Cava Filters (IVCF), Percutaneous Thrombectomy Devices), End User (Hospitals, Diagnostic Centers, Others) – Industry Trends and Forecast to 2032
.
The Global Clot Management Devices Market size was valued at USD 1.85 USD Billion in 2024.
The Global Clot Management Devices Market is projected to grow at a CAGR of 5.05% during the forecast period of 2025 to 2032.
The major players operating in the market include Angio DynamicsInc. , Applied Medical Resources Corporation , Bayer AG , Boston Scientific Corporation , Edwards Lifesciences Corporation , EKOS Corporation , Janssen PharmaceuticalsInc. , Medtronic , Stryker and Volcano Corporation .
The market report covers data from the U.S., Canada and Mexico in North America, Germany, France, U.K., Netherlands, Switzerland, Belgium, Russia, Italy, Spain, Turkey, Rest of Europe in Europe, China, Japan, India, South Korea, Singapore, Malaysia, Australia, Thailand, Indonesia, Philippines, Rest of Asia-Pacific (APAC) in the Asia-Pacific (APAC), Saudi Arabia, U.A.E, South Africa, Egypt, Israel, Rest of Middle East and Africa (MEA) as a part of Middle East and Africa (MEA), Brazil, Argentina and Rest of South America as part of South America.
